Results 251 to 260 of about 105,790 (331)
Engineering and Characterisation of Novel Nanomedicine Formulations, 2nd Edition [PDF]
openalex +1 more source
SeZM NPs selectively target M2b macrophages through mannose–MRC1 (CD206) recognition, enhance GPX1 biosynthesis, and suppress mitochondrial ROS generation, oxidative stress, and JAK–STAT signaling. This dual regulation reduces pro‐inflammatory cytokine release, limits immune cell infiltration and fibrosis, and preserves renal function, providing a ...
Haoran Lv +16 more
wiley +1 more source
Bridging the Gap: The Role of Advanced Formulation Strategies in the Clinical Translation of Nanoparticle-Based Drug Delivery Systems. [PDF]
Herdiana Y.
europepmc +1 more source
Fluorescent Silica Nanoparticles with Efficient Urinary Excretion for Nanomedicine
Andrew Burns +8 more
openalex +2 more sources
Compared to untargeted therapy, the targeted nanocarrier, Angiopep‐2‐conjugated Lipid Nanoparticle (A‐LNP) loaded with TGN‐020 (TGN), selectively accumulated in stroke‐injured regions. It suppressed local aquaporin‐4 (AQP4) overexpression, thereby alleviating cerebral edema and hypoperfusion while preserving global glymphatic clearance.
Lei Jin +18 more
wiley +1 more source
Polymeric Materials in Biomedical Engineering: A Bibliometric Mapping. [PDF]
Veres C, Tănase M, Szabo DA.
europepmc +1 more source
Cell‐Free DNA‐Based Theranostics for Inflammatory Disorders
Summary on the dual potential of cfDNA as biomarkers and therapeutic targets for inflammatory disorders. Figure was created with BioRender.com. ABSTRACT Inflammatory disorders are characterized by immune‐mediated inflammatory cascades that can affect multiple organs.
Jiatong Li +7 more
wiley +1 more source
In vitro and in vivo Evaluation of Folic Acid Modified DOX-Loaded <sup>32</sup>P-nHA Nanoparticles in Prostate Cancer Therapy [Retraction]. [PDF]
europepmc +1 more source
Understanding obesity-cancer crosstalk to inform the immunomodulatory roles of anti-obesity nanotherapeutics. [PDF]
Zhou F, Li X, Jiang J, Zhang L.
europepmc +1 more source

